Source disclosure: February 13, 2026
TOWA PHARMACEUTICAL CO.,LTD. [4553.T]
TOKYO, Feb 13 (Pulse News Wire) – TOWA PHARMACEUTICAL CO.,LTD. (4553.T) released its earnings presentation for Q3 FY2026.
3% YoY). 6 billion. 8 billion.
By segment: : ¥2.02 billion. 6 billion.
Note: Financial figures from the earnings presentation have been removed pending correction. For accurate figures, refer to the company's earnings summary (kessan tanshin) filed separately on TDNet.
AI-translated content. 🟢 Confidence: High See terms •Financial results — FY2026/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥204,065M | +5.3% |
| Operating profit | ¥19,490M | +4.7% |
| Net profit | ¥17,082M | +16.8% |
Next period forecast
Revenue
¥280,000M
+7.9%Op. profit
¥27,000M
+16.2%Net profit
¥17,700M
-6.8%Source: TDNet filing · Figures in millions of yen
💬 Help us improve translation quality
Notice any errors in this article? Let us know with one click.